THALES financials
THALES
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
529900FNDVTQJOVVPZ19 Financial statements
(EUR, as reported — unscaled; 111 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Cost of sales | €16.28B | €15.20B |
| Distribution costs | €1.58B | €1.59B |
| Operating profit (EBIT) | €2.06B | €1.26B |
| Income tax expense | €396.5M | €247.3M |
| Profit for the year | €1.64B | €1.34B |
| — attributable to owners | €1.67B | €1.42B |
| — attributable to NCI | -€34.2M | -€75.1M |
| Total comprehensive income | €1.23B | €1.54B |
| Per share | ||
| Basic EPS | €8.15 | €6.91 |
| Diluted EPS | €8.13 | €6.89 |
| Free cash flow / share | €12.71 | €10.33 |
| Cash flow statement | ||
| Net cash from operating activities | €3.32B | €2.64B |
| Net cash from investing activities | -€909.8M | -€62.8M |
| Net cash from financing activities | -€2.66B | -€2.00B |
| Proceeds from borrowings | €51.1M | €158.2M |
| Repayments of borrowings | €1.88B | €1.16B |
| Balance sheet | ||
| Total assets | €39.16B | €39.99B |
| Non-current assets | €17.83B | €18.69B |
| Intangible assets & goodwill | €8.53B | €8.90B |
| Current assets | €21.32B | €21.30B |
| Cash & equivalents | €4.45B | €4.77B |
| Total equity | €7.99B | €7.56B |
| — attributable to owners | €7.97B | €7.52B |
| Non-controlling interests | €19.3M | €42.9M |
| Non-current liabilities | €5.93B | €6.78B |
| Long-term borrowings | €4.00B | €4.55B |
| Current liabilities | €25.24B | €25.66B |
| Short-term borrowings | €2.13B | €3.27B |
| Deferred tax liabilities | €509.6M | €634.8M |
| Derived metrics | ||
| Free cash flow | €2.57B | €2.01B |
| Operating margin | 9.3% | 6.1% |
| Net margin | 7.4% | 6.5% |
| Return on equity | 20.5% | 17.8% |
| Cash conversion ratio | 2.03× | 1.96× |
| Capex coverage | 4.39× | 4.23× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €1.09B | €1.16B |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €0 | €157.6M |
| Adjustments For Income Tax Expense | €396.5M | €247.3M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | €143.3M | €148.8M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €198.4M | €95.1M |
| Cancellation of Treasury Shares | €0 | €0 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€76.9M | €1.98B |
| Cash Flows From Used In Financing Activities Continuing Operations | -€2.66B | -€2.00B |
| Cash Flows From Used In Financing Activities Discontinued Operations | €0 | -€7.3M |
| Cash Flows From Used In Investing Activities Continuing Operations | -€909.8M | -€27.9M |
| Cash Flows From Used In Investing Activities Discontinued Operations | €0 | -€34.9M |
| Cash Flows From Used In Operating Activities Continuing Operations | €3.32B | €2.75B |
| Cash Flows From Used In Operating Activities Discontinued Operations | €0 | -€108.6M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €3.37B | €3.18B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €9.2M | €1.21B |
| Cash Receipts From Repayment of Advances and Loans Made To Related Parties | €0 | €142.6M |
| Current Advances To Suppliers | €892.0M | €895.7M |
| Current Contract Assets | €3.54B | €3.24B |
| Current Contract Liabilities | €12.38B | €11.54B |
| Current Derivative Financial Assets | €149.9M | €135.1M |
| Current Derivative Financial Liabilities | €151.2M | €352.7M |
| Current Tax Assets Current | €320.7M | €160.6M |
| Current Tax Liabilities | €241.9M | €193.0M |
| Deferred Tax Assets | €1.28B | €1.37B |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €780.7M | €708.4M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €2.2M | €14.3M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €3.90 | — |
| Dividends Received Classified As Operating Activities | €128.2M | €124.6M |
| Dividends Recognised As Distributions To Noncontrolling Interests | €1.2M | €14.5M |
| Dividends Recognised As Distributions To Owners of Parent | €780.7M | €708.4M |
| Dividends Recognised As Distributions To Owners Per Share | — | €3.70 |
| Equity and Liabilities | €39.16B | €39.99B |
| Expense of Restructuring Activities | €132.0M | €118.3M |
| General and Administrative Expense | €725.1M | €692.9M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €0 | €157.6M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €17.2M | €34.9M |
| Income Taxes Paid Refund Classified As Operating Activities | €413.0M | €185.3M |
| Increase Decrease In Cash and Cash Equivalents | -€320.6M | €559.8M |
| Increase Decrease Through Sharebased Payment Transactions | €37.3M | €60.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -€14.2M | -€13.7M |
| Increase Decrease Through Treasury Share Transactions | -€45.2M | -€275.4M |
| Intangible Assets Other Than Goodwill | €2.00B | €2.53B |
| Interest Income On Cash and Cash Equivalents | €116.8M | €123.5M |
| Interest Paid Classified As Operating Activities | €225.8M | €267.3M |
| Interest Received Classified As Operating Activities | €106.0M | €127.7M |
| Investment Accounted For Using Equity Method | €1.71B | €1.65B |
| Noncurrent Derivative Financial Liabilities | €0 | €0 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €140.8M | €160.6M |
| Noncurrent Provisions For Employee Benefits | €1.42B | €1.59B |
| Number of Shares Outstanding | 205.5M | 205.3M |
| Other Adjustments To Reconcile Profit Loss | €14.3M | €41.1M |
| Other Comprehensive Income | -€406.7M | €196.7M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | €11.0M | -€20.1M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €51.8M | €65.8M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €139.3M | -€84.2M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€586.2M | €241.3M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€466.0M | €176.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €59.3M | €20.0M |
| Other Current Financial Assets | €64.6M | €12.5M |
| Other Noncurrent Financial Assets | €277.5M | €371.6M |
| Other Shortterm Provisions | €1.68B | €1.96B |
| Payments To Acquire Or Redeem Entitys Shares | €45.2M | €275.4M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €10.4M | €6.3M |
| Profit Loss From Continuing Operations | €1.64B | €932.3M |
| Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders of Parent Entity | €1.67B | €1.01B |
| Profit Loss From Discontinued Operations | €0 | €412.1M |
| Profit Loss From Discontinued Operations Attributable To Ordinary Equity Holders of Parent Entity | €0 | €412.1M |
| Property Plant and Equipment Including Rightofuse Assets | €3.90B | €3.72B |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €756.7M | €623.1M |
| Research and Development Expense | €1.33B | €1.27B |
| Reserve of Exchange Differences On Translation | -€726.5M | -€108.5M |
| Revenue From Contracts With Customers | €22.14B | €20.58B |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | -€19.1M | €1.8M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Before Tax | €13.7M | €6.6M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €198.4M | €95.1M |
| Treasury Shares | €90.5M | €92.5M |
Methodology
Every line item above is a fact tagged in THALES's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.